General Information of This Metabolic Reaction (MR) (ID:
MR006031) |
Formula |
|
Reactant |
Belinostat |
Product |
Belinostat Amide |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2A6 (CYP2A6)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies
|
2 |
Glucuronidation by UGT1A1 is the dominant pathway of the metabolic disposition of belinostat in liver cancer patients. PLoS One. 2013;8(1):e54522.
|
3 |
In vitro characterization of belinostat glucuronidation: demonstration of both UGT1A1 and UGT2B7 as the main contributing isozymes
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.